Recruiting

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)

I4V-MC-JAIM - ClinicalTrials.gov - NCT03843125

The reason for this long term study is to see how safe and effective the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE) who have completed the final treatment visit of study I4V-MC-JAHZ (NCT03616912) or study I4V-MC-JAIA (NCT03616964).
How long will I be in the trial?
The study will last about 156 weeks and may include up to 16 visits.
Email
Recruiting

A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE)

I4V-MC-JAIM - ClinicalTrials.gov - NCT03843125

The reason for this long term study is to see how safe and effective the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE) who have completed the final treatment visit of study I4V-MC-JAHZ (NCT03616912) or study I4V-MC-JAIA (NCT03616964).
How long will I be in the trial?
The study will last about 156 weeks and may include up to 16 visits.
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participant must have completed the final treatment study visit of an originating study, such as study JAHZ (NCT03616912) or Study JAIA (NCT03616964).

Participants must NOT

Trial Summary

Conditions the trial is for

Lupus (SLE)

What the trial is testing?

Baricitinib

Could I receive a Placebo?

no

Enrollment Goal

1100

Trial Dates

September 2019 - May 2025

Trial Phase

3

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participant must have completed the final treatment study visit of an originating study, such as study JAHZ (NCT03616912) or Study JAIA (NCT03616964).

Participants must NOT

Trial Summary

Conditions the trial is for

Lupus (SLE)

What the trial is testing?

Baricitinib

Could I receive a Placebo?

no

Enrollment Goal

1100

Trial Dates

September 2019 - May 2025

Trial Phase

3

Not the right fit? Sign up to receive updates on new Lupus (SLE) trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

By clicking the checkbox and using the map, you agree to allow Google Maps to collect your personal information in accordance with their Privacy Policy

Lupus (SLE) Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?